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2. Experimental design, materials and methods
The experimental design of this study is to model the Nos3-related
cardiac defects using an induced pluripotent stem cell (iPSC) platform
and investigate the underlying disease pathogenesis by mapping the
transcriptome proﬁles using tail tip derived iPSCs of wild type (WT)
CD1 (Harlan Laboratories, Indianapolis, IN) and Nos3−/− (B6.129P2-
Nos3tm1unc/J, The Jackson Laboratory, Bar Harbor, ME) mice back to
the gene expression proﬁles of corresponding embryonic heart tissues.
Sample source
location
Nos3 (B6.129P2-Nos3tm1unc/J, The Jackson Laboratory, Bar
Harbor,ME) and wild type (WT) CD1 (Harlan Laboratories,
Indianapolis, IN)the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Overall strategy of study design and data analysis. Transcriptome proﬁling using microarray was performed on embryonic heart tissues (in utero, left orange box). In vitro disease
modeling for Nos3-related cardiac defects was conducted using induced pluripotent stem cells (iPSCs) derived from ﬁbroblast (right green box). Microarray experiments were performed
on both iPSCs and differentiated cardiomyocytes. Systems biology study integrated both in utero and in vitro transcriptome information to pinpoint the disease associated genes and
networks (central circular plot).
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tissues as a gold standard. In brief, WT and Nos3−/− embryos were
harvested at 14.5 days post coitum (E14.5) and dissected for embryonic
heart tissues. Biological triplicate sampleswere collected for microarray
experiments with each sample containing tissues from 15 to 30 embry-
os. To accurately proﬁle the transcriptomes in different heart chambers,
left and right ventricular tissues (LV and RV) were microdissected for
RNA extraction. For in vitromicroarray experiments, tail tip ﬁbroblasts
were harvested from the distal part of the tail of WT and Nos3−/−
adult male mice. After culturing for 1–2 weeks in Dulbecco's modiﬁed
Eagle's medium (DMEM, Life Technologies, Grand Island, NY), tail tip ﬁ-
broblasts were infected with viral vectors from the CytoTuneTM-iPS 2.0
Sendai Reprogramming Kit (Life Technologies, Grand Island, NY).
Sendai viral vectors encoding hKOS (hKlf4, hOct4, hSox2), hcMyc, and
hKlf4 were introduced at multiplicities of infection of 5:5:3, respective-
ly. The detailed process is published in the original paper [1]. Emerging
WT andNos3−/− iPSC colonies were harvested for RNA extraction and
microarray analysis. To model the Nos3-related heart defects in vitro,
WT andNos3−/− iPSCswere spontaneously differentiated into beating
cardiomyocytes and allowed to expand until Day 11 of differentiation
with medium refreshed every other day. Differentiated cardiomyocytes
were identiﬁed by beating activity and expression of α-actinin. In
addition, mouse embryonic stem cells (mESCs; R1, G4, CGR8) were
used as additional quality controls for in vitro cardiac differentiation.
RNA from embryonic tissue samples, iPSCs, and differentiated
cardiomyocytes was extracted with the RNeasy kit (Qiagen, German-
town, MD) for microarray experiments. GeneChip Mouse Genome 430
2.0 Arrays (Affymetrix, Santa Clara, CA) were used to proﬁle the tran-
scriptome in both tissue and cell line samples. Stringent quality assess-
ment and quality control procedures were performed in this study,
which are described in our previous publication [2]. According tostandard Affymetrix microarray protocol, Biotinylated complementary
RNA (cRNA)was prepared from100 ng total RNA. Following fragmenta-
tion, 10 μg of cRNA was hybridized for 16 h at 45 °C on the microarray.
GeneChips were washed and stained in the Affymetrix Fluidics Station
450 and then scanned using the GeneChip Scanner 3000 7G.
Microarray data was normalized and processed using the RMA
method [3,4] to calculate the gene expression matrix. The differential
analysis was performed using the LIMMAmethod [5]. Pairwise differen-
tial analyses were performed between the following groups: WT LV vs.
Nos3−/− LV, WT RV vs. Nos3−/− RV, WT iPSCs vs. Nos3−/− iPSCs,
WT iPSC-derived cardiomyocytes vs. Nos3−/− iPSC-derived
cardiomyocytes (Fig. 1). Mouse ESC and ESC-derived cardiomyocytes
were used as positive controls in clustering and PCA analyses.
Following differential analysis, a systems biology strategy was applied
to integrate differential genes from both in utero and in vitromicroarray
experiments along with gene interaction information to pinpoint the
concordant genes and network hubs.References
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